Evidence map›Paper›PMID 27899971›Full record

ArticleOncology letters2016

The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia.

Giovanna Carrà, Cristina Panuzzo, Sabrina Crivellaro, Deborah Morena, Riccardo Taulli, Angelo Guerrasio, Giuseppe Saglio, Alessandro Morotti

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Giovanna CarràDepartment of Clinical and Biological Sciences, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
Cristina PanuzzoDepartment of Clinical and Biological Sciences, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
Sabrina CrivellaroDepartment of Clinical and Biological Sciences, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
Deborah MorenaDepartment of Oncology, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
Riccardo TaulliDepartment of Oncology, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
Angelo GuerrasioDepartment of Clinical and Biological Sciences, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
Giuseppe SaglioDepartment of Clinical and Biological Sciences, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
Alessandro MorottiDepartment of Clinical and Biological Sciences, 'San Luigi Gonzaga' University Hospital, School of Medicine, University of Turin, 10043 Turin, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Philadelphia chromosome-positive (Ph

Indexed as

acute lymphoblastic leukemiaBCR-ABLherpesvirus-associated ubiquitin-specific proteaseherpesvirus-associated ubiquitin-specific protease inhibitorsp190p53

Identifiers

PMID27899971
PMCPMC5103907
OpenAlexW2511145596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.